These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10383736)

  • 1. Predominant expression of Fas (CD95) ligand in metastatic melanoma revealed by longitudinal analysis.
    Terheyden P; Siedel C; Merkel A; Kämpgen E; Bröcker EB; Becker JC
    J Invest Dermatol; 1999 Jun; 112(6):899-902. PubMed ID: 10383736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas.
    Shukuwa T; Katayama I; Koji T
    Mod Pathol; 2002 Apr; 15(4):387-96. PubMed ID: 11950912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis, Fas and Fas-ligand expression in melanocytic tumors.
    Sprecher E; Bergman R; Meilick A; Kerner H; Manov L; Reiter I; Shafer Y; Maor G; Friedman-Birnbaum R
    J Cutan Pathol; 1999 Feb; 26(2):72-7. PubMed ID: 10082396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Fas ligand (CD95L) in primary malignant melanoma and melanoma metastases is associated with overall survival.
    Neuber K; Eidam B
    Onkologie; 2006 Sep; 29(8-9):361-5. PubMed ID: 16974112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
    Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F
    J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.
    Rivoltini L; Radrizzani M; Accornero P; Squarcina P; Chiodoni C; Mazzocchi A; Castelli C; Tarsini P; Viggiano V; Belli F; Colombo MP; Parmiani G
    J Immunol; 1998 Aug; 161(3):1220-30. PubMed ID: 9686582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of Fas and Fas-ligand expression during melanoma progression.
    Soubrane C; Mouawad R; Antoine EC; Verola O; Gil-Delgado M; Khayat D
    Br J Dermatol; 2000 Aug; 143(2):307-12. PubMed ID: 10951137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.
    Shimonishi T; Isse K; Shibata F; Aburatani I; Tsuneyama K; Sabit H; Harada K; Miyazaki K; Nakanuma Y
    Hepatology; 2000 Oct; 32(4 Pt 1):761-9. PubMed ID: 11003620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis and Fas-ligand expression correlate to the histopathological grade of gastric smooth muscle tumors.
    Liu Y; Chen C; Chen C; Hsieh H; Chang C; Shyu J; Yen C; Harn H
    J Surg Res; 2001 Feb; 95(2):92-8. PubMed ID: 11162031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous apoptosis of CD8+ T lymphocytes in peripheral blood of patients with advanced melanoma.
    Saito T; Dworacki G; Gooding W; Lotze MT; Whiteside TL
    Clin Cancer Res; 2000 Apr; 6(4):1351-64. PubMed ID: 10778963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax.
    Aggarwal S; Gupta S
    J Immunol; 1998 Feb; 160(4):1627-37. PubMed ID: 9469419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas-related apoptosis in gastric adenocarcinoma.
    Lim SC
    Oncol Rep; 2003; 10(1):57-63. PubMed ID: 12469145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma.
    Dworacki G; Meidenbauer N; Kuss I; Hoffmann TK; Gooding W; Lotze M; Whiteside TL
    Clin Cancer Res; 2001 Mar; 7(3 Suppl):947s-957s. PubMed ID: 11300496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape.
    Hahne M; Rimoldi D; Schröter M; Romero P; Schreier M; French LE; Schneider P; Bornand T; Fontana A; Lienard D; Cerottini J; Tschopp J
    Science; 1996 Nov; 274(5291):1363-6. PubMed ID: 8910274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas (CD95/Apo-1)/Fas ligand expression in neonates with pontosubicular neuron necrosis.
    van Landeghem FK; Felderhoff-Mueser U; Moysich A; Stadelmann C; Obladen M; Brück W; Bührer C
    Pediatr Res; 2002 Feb; 51(2):129-35. PubMed ID: 11809905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.
    Koyama S; Koike N; Adachi S
    J Cancer Res Clin Oncol; 2002 Feb; 128(2):73-9. PubMed ID: 11862476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: a mechanism for the loss of gamma delta T cells in patients with pulmonary tuberculosis.
    Li B; Bassiri H; Rossman MD; Kramer P; Eyuboglu AF; Torres M; Sada E; Imir T; Carding SR
    J Immunol; 1998 Aug; 161(3):1558-67. PubMed ID: 9686624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas ligand reduces viability in primary melanoma short-term cell cultures more than in metastatic melanoma short-term cell cultures.
    Hofbauer GF; Hatta N; Daigle I; Hemmi S; Spanaus Schlapbach K; Willers J; Burg G; Simon HU; Dummer R
    Dermatology; 2005; 211(4):318-24. PubMed ID: 16286739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor infiltrating lymphocytes in uveal melanoma: a link with clinical behavior?
    Staibano S; Mascolo M; Tranfa F; Salvatore G; Mignogna C; Bufo P; Nugnes L; Bonavolontà G; De Rosa G
    Int J Immunopathol Pharmacol; 2006; 19(1):171-9. PubMed ID: 16569355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.